Curiox BioSystems Co Ltd
KOSDAQ:445680
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
C
|
Curiox BioSystems Co Ltd
KOSDAQ:445680
|
1.9T KRW |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.4B USD |
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
189.6B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
172.4B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
127.3B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.9B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.8B EUR |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.4B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
36.6B USD |
Loading...
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
226.4B CNY |
Loading...
|
|
| JP |
|
Fujifilm Holdings Corp
TSE:4901
|
3.7T JPY |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
Curiox BioSystems Co Ltd
Glance View
Curiox BioSystems Co Ltd is a KR-based company operating in industry. The company is headquartered in Seoul, Seoul. The company went IPO on 2023-08-10. Curiox BioSystems Co Ltd is a Korea-based company primarily engaged in the manufacture and sale of automation equipment and consumables for cell analysis processes. The firm is engaged in the manufacture and sale of cell pretreatment automation devices, washing machines, plates and other products. In addition, the Company is engaged in the manufacture and sale of high-capacity adapters, strip spacers, buffer exchanger products and others.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Curiox BioSystems Co Ltd is 41.2%, which is below its 3-year median of 50%.
Over the last 2 years, Curiox BioSystems Co Ltd’s Gross Margin has decreased from 51.5% to 41.2%. During this period, it reached a low of 37.9% on Jun 30, 2025 and a high of 59.3% on Mar 31, 2025.
